Abiopharma

The companys financial results for the first quarter, 2026 were published abroad

Net Asset Value(s)

Robo.ai Announces Completion of 100% Acquisition of Neurovia AI, Solidifying AI Software Strategic Foundation

Ceased to be an interested party - Itamar Pitel

EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask

Private issuance of 389,889 series of warrants to employees and officers

Register of shareholders, changes and capital status – exercise of non-tradable warrants into ordinary shares

Linde Publishes 2025 Sustainable Development Report

Greenwich LifeSciences Provides Update Regarding Form 10-K Filing

Greenwich LifeSciences Provides Update Regarding Form 10-K Filing